Epigenetic regulation of Epstein–Barr virus: From bench to bedside.

Autor: Gao, Xiao¹ (AUTHOR), Yang, Hao‐Xu¹ (AUTHOR), Cheng, Shu¹ (AUTHOR), Cai, Hua‐Man¹ (AUTHOR), Xiong, Jie¹ (AUTHOR) xiongjie_sih@163.com, Zhao, Wei‐Li^1,2 (AUTHOR) zhao.weili@yahoo.com

Publikováno v: Clinical & Translational Discovery. Oct2024, Vol. 4 Issue 5, p1-13. 13p.

Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.

Autor: Jog NR; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., McClain MT; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Heinlen LD; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Gross T; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Towner R; Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Guthridge JM; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Axtell RC; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Pardo G; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Harley JB; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Department of Veterans Affairs VA Medical Center, Cincinnati, OH, USA., James JA; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: Judith-James@omrf.org.

Publikováno v: Journal of autoimmunity [J Autoimmun] 2020 Jan; Vol. 106, pp. 102332. Date of Electronic Publication: 2019 Sep 09.

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.

Autor: Jog NR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Young KA; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, Colorado, USA., Munroe ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Harmon MT; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Guthridge JM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Kelly JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Gilkeson GS; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Weisman MH; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Karp DR; Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Gaffney PM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Harley JB; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.; US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States., Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Norris JM; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, Colorado, USA., James JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA judith-james@omrf.org.; Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Sep; Vol. 78 (9), pp. 1235-1241. Date of Electronic Publication: 2019 Jun 19.

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Autor: Corradetti C; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140., Jog NR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104., Cesaroni M; Janssen Research and Development, LLC, Spring House, PA 19477; and., Madaio M; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912., Caricchio R; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140; roc@temple.edu.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Jan 15; Vol. 200 (2), pp. 512-522. Date of Electronic Publication: 2017 Dec 13.

The study of anti-idiotype antibody and antinuclear antibodies (ANA) in people receiving three doses of the COVID-19 vaccine.

Autor: Chegni, Hamid¹ (AUTHOR) h.chegini2010@yahoo.com, Babaii, Hadise² (AUTHOR), Pouran, Fatemeh² (AUTHOR)

Publikováno v: European Journal of Inflammation. 5/6/2024, p1-11. 11p.